Total
0
Shares
Pure Extracts (CSE:PULL) submits licence application for Lion’s Mane functional mushroom product
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Pure Mushrooms Corporation, a subsidiary of Pure Extracts (PULL), has submitted a Class 3 natural health product licence application for its Lion’s Mane product
  • Once it is licenced, the Lion’s Mane product will be available on the company’s Amazon store alongside its reishi and maitake functional wellness products
  • The company expects to launch the Class 3 product in early 2022
  • Pure Extracts Technologies is a plant-based extraction company
  • Pure Extracts Technologies Corp. (PULL) is down 2.53 per cent, trading at $0.385 per share

Pure Mushrooms Corporation, a subsidiary of Pure Extracts (PULL), has submitted a product licence application for its Lion’s Mane product.

The Class 3 natural health product licence would allow Pure Mushrooms to include the product’s benefits for cognitive health in its description.

Once it is licenced, the Lion’s Mane product will be available on the company’s Amazon store alongside its reishi and maitake functional wellness products.

Ben Nikolaevsky, Pure Extracts CEO, commented on the product’s release to the company’s online store.

“The functional mushroom wellness market is experiencing robust sales as many consumers are trying to boost their immune systems in light of the COVID-19 pandemic.”

“As we build-out our mushroom extraction facility,” he added, “we plan to bring more products to market.”

The Class 1 Lion’s Mane product is expected to launch in the fourth quarter. The company will also release its new blended mushroom product at that time.

Once the Class 3 licence is approved, Pure Extracts will launch the Class 3 Lion’s Mane product, with an expected launch date of Q1 2022.

Pure Extracts Technologies is a plant-based extraction company that specializes in the processing of cannabis, hemp, and functional mushrooms.

The company’s new, state-of-the-art processing facility is located just 20 minutes north of Whistler, British Columbia.

Pure Extracts Technologies Corp. (PULL) is down 2.53 per cent, trading at $0.385 per share as of 11:23 am ET.

More From The Market Herald
Psyence Group (CSE:PSYG) and Pure Extracts (CSE:PULL) form psychedelics joint venture

" Psyence Group (CSE:PSYG) and Pure Extracts (CSE:PULL) form psychedelics joint venture

Pure Extracts (PULL) and Psyence Group (PSYG) have formed a JV for psychedelic medicinal mushroom extracts.
Levitee Labs - CEO, Pouya Farmand. - The Market Herald Canada

" Levitee Labs (CSE:LVT) announces DTC eligibility

Common shares of Levitee Labs (LVT) are now eligible to be electronically cleared and settled through the DTC.
Mindset Pharma (CSE:MSET) announces inclusion in the AdvisorShares Psychedelics Exchange Traded Fund

" Mindset Pharma (CSE:MSET) announces inclusion in the AdvisorShares Psychedelics Exchange Traded Fund

Mindset Pharma (MSET) has announced its inclusion in the NYSE-traded AdvisorShares Psychedelics ETF.
Clearmind Medicine (CSE:CMND) announces closing of private placement

" Clearmind Medicine (CSE:CMND) partners with The Hebrew University

Clearmind Medicine (CMND) has established a research and development partnership with the Yissum Research Development Company.